Budesonide, sold under the brand name Pulmicort among others, is a medication of the corticosteroid type. It is available as an inhaler, pill, nasal spray, and rectal forms. The inhaled form is used in the long-term management of asthma and chronic obstructive pulmonary disease
A Anant Labs fabrica e fornece impurezas de Budesonide de alta qualidade para o mercado global. Nossas impurezas EP de Budesonide são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.
Sinônimos
budesonide51333-22-3PulmicortRhinocortEntocortPreferidRhinocort AquaEntocort ECUcerisPulmicort RespulesPulmicort FlexhalerBudenofalkBudesonidoBudesonidumPulmaxanRhinocort AllergyDTXSID8020202Pulmicort turbuhalerS-1320EOHILIAMAP-0010BudesonidaEltairQ3OKS62Q6XORTIKOSCHEBI:3207MAP0010R01AD05NSC-757788(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dioneDTXCID50820058UCERIS COMPONENT BUDESONIDEBREZTRI COMPONENT BUDESONIDEAIRSUPRA COMPONENT BUDESONIDE(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dionePregna-1,4-diene-3,20-dione,16,17-(butylidenebis(oxy))-11,21-dihydroxy-, (11beta,16alpha)-Tarpeyo(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosa-14,17-dien-16-oneAircortBudecortButacortNasocortEntocort crDuoresp spiromaxBudeflam aquanaseBudelin novolizerPulmicort l.s.(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo(10.8.0.0^(2,9).0^(4,8).0^(13,18))icosa-14,17-dien-16-oneRhinocort aqua 64Budesonide InhalationRefChem:5621Budesonide Inhalation SuspensionA07EA06D07AC09R03BA02BUDESONIDE (ENTERIC COATED)257-139-7CortimentSpirocortBudesonCortiventMicronylRespulesBidienMFCD00083259Budesonide (Standard)MLS000028507(RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehydeBudesonide MMXRhinocort alpha(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-oneSMR000058337Budecort InhalerBudesonidum [INN-Latin]Budesonido [INN-Spanish]InflammideBudiairMiflonideFvolirBudesonide [USAN:INN:BAN:JAN]Pulmaxan turbohalerPulmicort (TN)Pulmicort TopinasalRhinocort (TN)(6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-6a,6b,7,8,8a,8b,11a,12,12a,12b-decahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4(2H)-oneBudesonide EasyhalerS 1320CCRIS 5230Entocort EC (TN)16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dioneSR-01000000101EINECS 257-139-7UNII-Q3OKS62Q6XJorvezaUltesaNoexGiona EasyhalerInflammide;Pulmicort;Rhinocort;Demotest;Entocort;Lisoflam;Prederid;Preferid;Pulmaxan;Budamax;Budeson;Nohalon;Budesonide CRSOlfex;Budesonide - IPNCGC00016862-01Budesonide; 16a,17-[(1RS)-butylidenebis(oxy)]-11ss,21-dihydroxypregna-1,4-diene-3,20-dionePregna-1,4-diene-3,20-dione, 16,17-[butylidenebis(oxy)]-11,21-dihydroxy-, (11.beta.,16.alpha.)-Prestwick_840CAS-51333-22-3Uceris (TN)Budesonide (Mixture of Diastereomers)Budesonide, >=99%BUDESONIDE [MI]BUDESONIDE [INN]BUDESONIDE [JAN]Opera_ID_1696Prestwick0_000518Prestwick1_000518Prestwick2_000518Prestwick3_000518BUDESONIDE [USAN]BUDESONIDE [VANDF]Epitope ID:161750B 7777SCHEMBL4096BUDESONIDE [USP-RS]BUDESONIDE [WHO-DD]CHEMBL1370Lopac0_000174BSPBio_000475MLS001077323MLS002207112orb134514Budesonide (anti-inflammatory)SPBio_002396BPBio1_000523Budesonide (JP18/USP/INN)Budesonide - Bio-X trade markGTPL7434BUDESONIDE [ORANGE BOOK]HSDB 8279BUDESONIDE [EP MONOGRAPH]MSK2236BUDESONIDE [USP MONOGRAPH]HMS1569H17HMS2096H17HMS2232D17HMS3259H07HMS3260D09HMS3413B08HMS3413P17HMS3677B08HMS3677P17HMS3713H175-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-oneEohilia (budesonide oral suspension)Tox21_110653Tox21_201827Tox21_302815Tox21_500174BDBM50354850EBC-27074HY-13580RMSK2236-100ASYMBICORT COMPONENT BUDESONIDEBudesonide for system suitability CRSAKOS015969655MSK2236-1000AAC-4697CCG-204269CS-2063DB01222FB19346KS-1162LP00174NC00626NSC 757788SDCCGSBI-0050162.P002(+)-16alpha,17alpha-Butylidenedioxy-11beta,21-dihydroxy-1,4-pregnadiene-3,20-dione11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dioneNCGC00021318-05NCGC00021318-06NCGC00021318-08NCGC00021318-18NCGC00089747-04NCGC00256415-01NCGC00259376-01NCGC00260859-01BB164267Budesonide 100 microg/mL in AcetonitrileCPD000058337FB173257HY-13580Pregna-1,4-diene-3,20-dione, 16,17-(butylidenebis(oxy))-11,21-dihydroxy-, (11-beta,16-alpha)-Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dioneB3909B8112CS-0695032EU-0100174NS00000099Budesonide Solution in Acetonitrile, 100ug/mLD00246Budesonide Solution in Acetonitrile, 1000ug/mLEN300-19737584Q422212SR-01000000101-2SR-01000000101-6BRD-A34299591-001-03-4BRD-A34299591-001-22-4BRD-A34299591-001-25-7BRD-A34299591-001-26-5Budesonide Working Standard (Secondary Reference Standard)Budesonide, European Pharmacopoeia (EP) Reference StandardBudesonide, United States Pharmacopeia (USP) Reference StandardBudesonide, Pharmaceutical Secondary Standard; Certified Reference Material(11b,16a)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-Hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H,8H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-6b-Glycoloyl-5-hydroxy-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one(6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one
